Keyword: Bill and Melinda Gates Foundation
The two new grants will support development of universal flu and malaria vaccines leveraging CureVac’s RNActive mRNA-based platform.
Here is some other vaccine news of note for the week.
An investment fund formed by J.P. Morgan and the Gates Foundation, Global Health Investment Fund led Themis' €10 million series C.
Johnson & Johnson and partners on Thursday pushed their promising "mosaic" HIV vaccine candidate into efficacy testing.
Serum Institute of India has new results from a phase 3 trial of its rotavirus vaccine as it preps to deliver millions of doses.
Nonprofit PATH secured a major commitment from the Gates Foundation for its new vaccine group.
Gavi's vaccine initiative will have saved 20 million lives and $350 billion in healthcare costs by 2020, a recent study found.
Sanofi Pasteur’s chief quality officer says vaccinemakers need help tackling a lurking challenge: global regulatory entanglements.
Inovio’s Zika and MERS vaccine candidates, both the first to undergo human testing in those diseases, turned in some positive early data.
Drugmakers have joined with governments and nonprofits around the world to launch an alliance that’ll take a proactive approach to potential deadly outbreaks.